343 related articles for article (PubMed ID: 26910380)
1. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
[TBL] [Abstract][Full Text] [Related]
2. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
Kausar M; Husain S; Hussain R
Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
[TBL] [Abstract][Full Text] [Related]
4. Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial.
Morris R; Sunesara I; Darby M; Novotny S; Kiprono L; Bautista L; Sawardecker S; Bofill J; Anderson B; Martin JN
J Matern Fetal Neonatal Med; 2016; 29(2):171-6. PubMed ID: 25483419
[TBL] [Abstract][Full Text] [Related]
5. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
[TBL] [Abstract][Full Text] [Related]
6. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
Gaynor MF; Wright GC; Vondracek S
Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
[TBL] [Abstract][Full Text] [Related]
7. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
[TBL] [Abstract][Full Text] [Related]
8. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
Mabie WC; Gonzalez AR; Sibai BM; Amon E
Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
[TBL] [Abstract][Full Text] [Related]
9. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Hussein M; Mooij JM; Roujouleh H
Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
[TBL] [Abstract][Full Text] [Related]
10. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
[TBL] [Abstract][Full Text] [Related]
11. Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
Hjertberg R; Faxelius G; Lagercrantz H
J Perinat Med; 1993; 21(1):69-75. PubMed ID: 8487154
[TBL] [Abstract][Full Text] [Related]
12. Hypertensive Emergencies in Pregnancy.
Olson-Chen C; Seligman NS
Crit Care Clin; 2016 Jan; 32(1):29-41. PubMed ID: 26600442
[TBL] [Abstract][Full Text] [Related]
13. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
[TBL] [Abstract][Full Text] [Related]
14. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
Obstet Gynecol; 2011 Dec; 118(6):1465-1468. PubMed ID: 22105295
[TBL] [Abstract][Full Text] [Related]
15. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Sridharan K; Sequeira RP
Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
[TBL] [Abstract][Full Text] [Related]
16. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
[TBL] [Abstract][Full Text] [Related]
17. Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
Barton JR; Sibai BM
Clin Obstet Gynecol; 2017 Mar; 60(1):198-205. PubMed ID: 28005594
[TBL] [Abstract][Full Text] [Related]
18. Does labetalol predispose to pulmonary edema in severe pregnancy-induced hypertensive disease?
Gilson GJ; Kramer RL; Barada C; Izquierdo LA; Curet LB
J Matern Fetal Med; 1998; 7(3):142-7. PubMed ID: 9642612
[TBL] [Abstract][Full Text] [Related]
19. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
